Literature DB >> 30310694

Highlights from the 2018 European Respiratory Society Congress presentations on interstitial lung diseases.

Tiago M Alfaro1, Margarida Afonso1, Sebastiano Emanuele Torrisi2.   

Abstract

Entities:  

Year:  2018        PMID： 30310694      PMCID： PMC6174132          DOI： 10.21037/jtd.2018.08.101

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  15 in total

Review 1.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

2.  Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.

Authors:  Xiaoping Wu; Grace H Kim; Margaret L Salisbury; David Barber; Brian J Bartholmai; Kevin K Brown; Craig S Conoscenti; Jan De Backer; Kevin R Flaherty; James F Gruden; Eric A Hoffman; Stephen M Humphries; Joseph Jacob; Toby M Maher; Ganesh Raghu; Luca Richeldi; Brian D Ross; Rozsa Schlenker-Herceg; Nicola Sverzellati; Athol U Wells; Fernando J Martinez; David A Lynch; Jonathan Goldin; Simon L F Walsh
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 21.405

Review 3.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

4.  Frailty is common and strongly associated with dyspnoea severity in fibrotic interstitial lung disease.

Authors:  Kathryn M Milne; Joanne M Kwan; Sabina Guler; Tiffany A Winstone; Angela Le; Nasreen Khalil; Pat G Camp; Pearce G Wilcox; Christopher J Ryerson
Journal:  Respirology       Date:  2016-11-09       Impact factor: 6.424

Review 5.  Current understanding and management of pulmonary Langerhans cell histiocytosis.

Authors:  Robert Vassallo; Sergio Harari; Abdellatif Tazi
Journal:  Thorax       Date:  2017-07-08       Impact factor: 9.139

Review 6.  Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach.

Authors:  Anupam Kumar; Basem Abdelmalak; Yoshikazu Inoue; Daniel A Culver
Journal:  Lancet Respir Med       Date:  2018-02-01       Impact factor: 30.700

7.  Reliability and validity of 4-metre gait speed in COPD.

Authors:  Samantha S C Kon; Mehul S Patel; Jane L Canavan; Amy L Clark; Sarah E Jones; Claire M Nolan; Paul Cullinan; Michael I Polkey; William D-C Man
Journal:  Eur Respir J       Date:  2012-12-06       Impact factor: 16.671

Review 8.  Idiopathic pulmonary fibrosis.

Authors:  Fernando J Martinez; Harold R Collard; Annie Pardo; Ganesh Raghu; Luca Richeldi; Moises Selman; Jeffrey J Swigris; Hiroyuki Taniguchi; Athol U Wells
Journal:  Nat Rev Dis Primers       Date:  2017-10-20       Impact factor: 52.329

9.  Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease.

Authors:  Joshua J Solomon; Jonathan H Chung; Gregory P Cosgrove; M Kristen Demoruelle; Evans R Fernandez-Perez; Aryeh Fischer; Stephen K Frankel; Stephen B Hobbs; Tristan J Huie; Jill Ketzer; Amar Mannina; Amy L Olson; Gloria Russell; Yutaka Tsuchiya; Zulma X Yunt; Pearlanne T Zelarney; Kevin K Brown; Jeffrey J Swigris
Journal:  Eur Respir J       Date:  2015-11-19       Impact factor: 16.671

10.  Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Michael Kreuter; Svenja Ehlers-Tenenbaum; Karin Palmowski; Jacques Bruhwyler; Ute Oltmanns; Thomas Muley; Claus Peter Heussel; Arne Warth; Martin Kolb; Felix J F Herth
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.